| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| rp173718-500μg |
500μg |
期货  |
| |
| rp173718-1mg |
1mg |
期货 |
|
| 产品名称 | complement C5 |
|---|---|
| 规格或纯度 | Moligand™ |
| CAS编号和信息 | rp173718 |
|---|
| 1. Nishimura J, Yamamoto M, Hayashi S, Ohyashiki K, Ando K, Brodsky AL, Noji H, Kitamura K, Eto T, Takahashi T et al.. (2014) Genetic variants in C5 and poor response to eculizumab.. N Engl J Med, 370 (7): (632-9). [PMID:24521109] |
| 2. Fukuzawa T, Sampei Z, Haraya K, Ruike Y, Shida-Kawazoe M, Shimizu Y, Gan SW, Irie M, Tsuboi Y, Tai H et al.. (2017) Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases.. Sci Rep, 7 (1): (1080). [PMID:28439081] |
首页
400-620-6333
